Ca in situ skin of unsp upper limb, including shoulder refers to a localized malignant neoplasm of the skin that has not invaded deeper tissues. This condition is clinically significant as it can progress to invasive cancer if left untreated. The ICD-10 Code D04.60 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage cases effectively.
ICD-10 Code D04.60 represents a diagnosis of carcinoma in situ of the skin located on an unspecified upper limb, including the shoulder. This code is used when documenting cases where the cancerous cells are present but have not invaded surrounding tissues. It is essential for accurate clinical documentation and billing, particularly in outpatient and surgical settings.
Ca in situ skin of unsp upper limb, including shoulder is characterized by the presence of abnormal cells confined to the epidermis. This condition can arise from various factors, including UV exposure and genetic predisposition. Early detection and treatment are crucial to prevent progression to invasive cancer.
In SOAP notes, ICD-10 Code D04.60 is utilized to document the diagnosis of carcinoma in situ of the skin on the upper limb. It plays a critical role in capturing the patient's symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
ICD-10 Code D04.60 connects subjective patient reports and objective clinical findings to a formal diagnosis of skin cancer in situ. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Ca in situ skin of unsp upper limb, including shoulder typically involves surgical intervention. Prompt treatment is essential to prevent progression.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.60 is crucial for accurate billing in hospital, ER, or outpatient settings, particularly for skin cancer management.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, excised diameter 0.5 cm or less. |
| 11100 | Biopsy of skin, subcutaneous tissue, and/or mucous membrane. |
| 17000 | Destruction of skin lesions, up to 14 lesions. |
Common Questions About Using ICD-10 Code D04.60 for Ca in situ skin of unsp upper limb, including shoulder
What are the risk factors for developing Ca in situ skin?
Risk factors include excessive sun exposure, fair skin, a history of skin cancer, and certain genetic conditions. Regular skin checks are recommended for early detection.
How is Ca in situ skin treated?
Treatment typically involves surgical excision of the lesion. Other options may include cryotherapy or topical chemotherapy, depending on the specific case.
Is Ca in situ skin contagious?
No, carcinoma in situ is not contagious. It is a localized cancer that does not spread from person to person.
How often should follow-up appointments occur after treatment?
Follow-up appointments are generally recommended every 3 to 6 months for the first few years after treatment to monitor for recurrence or new lesions.
Clinical Notes
SOAP notes
DAP notes
AI medical notes